Testing a Tool That Estimates Seizure Risk in People With Epilepsy
Tests a tool that predicts seizure risk in adults with epilepsy.
Plain-language title generated from the registry record
Registry title: Prospective Evaluation of Probabilistic Predictions of Epileptic Seizure Risk Using the EPIDAY Tool
Key facts
- Where
- Paris, FranceSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT07068919, who can take part
Where in France
- Hôpital Pitié-Salpêtrière - AP-HPParis, FranceNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Trial code
- NCT07068919
- Record updated
- 15 September 2025
- Original description
Studies suggest the existence of a pre-critical state preceding the onset of an epileptic seizure. Identifying these states from self-reported prodromal symptoms, combined with machine learning algorithms, could help anticipate seizures.Read full original descriptionShow less
Prospective Evaluation of Probabilistic Predictions of Epileptic Seizure Risk Using the EPIDAY Tool
Studies suggest the existence of a pre-critical state preceding the onset of an epileptic seizure. Identifying these states from self-reported prodromal symptoms, combined with machine learning algorithms, could help anticipate seizures.
Inclusion: Age between 18 and 65; Focal epilepsy diagnosed for at least 18 months; Brain imaging as part of the etiological work-up for epilepsy showing no progressive cause; EEG compatible with the diagnosis of epilepsy within the last 10 years; At least 2 non-contiguous days of epileptic seizures per month, according to the patient; Ability of the patient to understand and use a mobile application on the personal smartphone; Free, informed and signed consent; Affiliation with a social security scheme (excluding AME).
Exclusion: Suspicion or diagnosis of other types of associated malaise: functional dissociative seizures, syncope or other malaise of non-neurological origin; Assessment of seizure frequency deemed unreliable by the investigator (eg. due to cognitive impairment); Inability to describe seizures accurately; Presence of more than 15 days with seizures per month; Participation in other interventional research or exclusion period not expired; Pregnant or breastfeeding woman; Patient under guardianship, curatorship, deprived of liberty.